Literature DB >> 22999526

Lack of association between TNF-α promoter polymorphisms and multiple myeloma: a meta-analysis.

Bing Li1, Xiao-Dan Wang, Xiaolei Sun, Jianxiong Ma, Yang Yang, Xinlong Ma.   

Abstract

Results of available literatures, which concerned the association between TNF-α promoter -238/-308 gene polymorphisms and multiple myeloma (MM), are of great controversy. A review was performed in studies reporting on the association between them. Odds ratios (ORs) with 95% confidence interval (CI) were used to evaluate the association. The pooled ORs indicated that there was no association between TNF-α -238/-308 polymorphisms and MM susceptibility in overall population. Sub-group analysis also confirmed that no evidence supported the relevance of TNF-α promoter -238/-308 gene polymorphisms with MM. Studies with large sample size and multi-ethnics may be needed to further explore the association between them.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22999526     DOI: 10.1016/j.leukres.2012.08.027

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  4 in total

1.  A role for activator of G-protein signaling 3 (AGS3) in multiple myeloma.

Authors:  Shan Shao; Xianting Huang; Yuchan Wang; Song He; Xiaohong Xu; Xinghua Zhu; Xiaojing Yang; Zongmei Ding; Li Yao; Yuejiao Huang; Chun Wang
Journal:  Int J Hematol       Date:  2013-12-05       Impact factor: 2.490

2.  The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple Myeloma.

Authors:  Szymon Zmorzyński; Sylwia Popek-Marciniec; Aneta Szudy-Szczyrek; Magdalena Wojcierowska-Litwin; Iwona Korszeń-Pilecka; Sylwia Chocholska; Wojciech Styk; Marek Hus; Agata A Filip
Journal:  Front Oncol       Date:  2019-10-11       Impact factor: 6.244

3.  Efficacy Evaluation of Inflammatory Mediators in the Treatment of Multiple Myeloma with Daratumumab.

Authors:  Jie Meng; Xiaoyu Zhao; Duanfeng Jiang; Changjiu Liang; Xunxiu Ji; Min Dong
Journal:  J Oncol       Date:  2022-08-27       Impact factor: 4.501

4.  Atiprimod triggered apoptotic cell death via acting on PERK/eIF2α/ATF4/CHOP and STAT3/NF-ΚB axis in MDA-MB-231 and MDA-MB-468 breast cancer cells.

Authors:  Ajda Coker-Gurkan; Esin Can; Semanur Sahin; Pınar Obakan-Yerlikaya; Elif-Damla Arisan
Journal:  Mol Biol Rep       Date:  2021-07-09       Impact factor: 2.316

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.